Quick Answer
Collagen Supplements and Skin has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Objective This study aimed to determine whether liposomal delivery enhances the effects of a collagen tripeptide-containing formulation on dermal structural and biomechanical parameters, as well as appearance-related skin properties, compared with a nonliposomal formulation and placebo.
Key Takeaways
- 01Objective This study aimed to determine whether liposomal delivery enhances the effects of a collagen tripeptide-containing formulation on dermal structural and biomechanical parameters, as well as appearance-related skin properties, compared with a nonliposomal formulation and placebo. [Lin YK (2026)]
- 02Methods In a randomized, double-blind, placebo-controlled trial, 75 healthy adults aged 25-65 years were assigned to receive placebo, a nonliposomal formulation containing collagen tripeptides, or a liposomal formulation containing collagen tripeptides (50 mL/day) for 8 weeks. [Lin YK (2026)]
- 03Results Supplementation with 10 g/day of BCP significantly reduced the number (p Conclusions A 12-week course of Peptpure ® BCP supplementation improved facial skin health, underlined by increased systemic levels of TGF-β and Klotho, suggesting activation of regenerative and antiaging pathways. [Paula-Vieira RHR (2026)]
- 04Introduction Collagen peptides are widely used to support skin health, but the immunological mechanisms mediating such effects remain unclear. [Paula-Vieira RHR (2026)]
The current Migaku evidence database contains 2 reusable source documents for Collagen Supplements and Skin. This answer focuses on safety, limits, and clinician-discussion contexts.
- Objective This study aimed to determine whether liposomal delivery enhances the effects of a collagen tripeptide-containing formulation on dermal structural and biomechanical parameters, as well as appearance-related skin properties, compared with a nonliposomal formulation and placebo. [Lin YK (2026); evidence level 2]
- Methods In a randomized, double-blind, placebo-controlled trial, 75 healthy adults aged 25-65 years were assigned to receive placebo, a nonliposomal formulation containing collagen tripeptides, or a liposomal formulation containing collagen tripeptides (50 mL/day) for 8 weeks. [Lin YK (2026); evidence level 2]
- Results Supplementation with 10 g/day of BCP significantly reduced the number (p Conclusions A 12-week course of Peptpure ® BCP supplementation improved facial skin health, underlined by increased systemic levels of TGF-β and Klotho, suggesting activation of regenerative and antiaging pathways. [Paula-Vieira RHR (2026); evidence level 4]
- Introduction Collagen peptides are widely used to support skin health, but the immunological mechanisms mediating such effects remain unclear. [Paula-Vieira RHR (2026); evidence level 4]
- So, this study investigated the effects of bioactive collagen peptide (BCP) supplementation on facial wrinkles, skin biophysical properties, and systemic levels of transforming growth factor-beta (TGF-β) and Klotho in sedentary middle-aged women. [Paula-Vieira RHR (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources